Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 101
Filter
2.
Br J Dermatol ; 147(1): 154-6, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12100200

ABSTRACT

Sarcoidosis is a disorder characterized by macrophage- and T-cell-mediated responses to as yet unidentified infectious antigens or autoantigens. We describe a 62-year-old woman with a 10-year history of orange-yellow plaques of sarcoidosis on her face. Her cutaneous lesions responded to topical tacrolimus ointment after unsuccessful treatment with topical and systemic corticosteroids. No adverse effects were noted with topical tacrolimus in this patient. We discuss the mode of action by which this immunosuppressive agent may act against sarcoidosis.


Subject(s)
Facial Dermatoses/drug therapy , Immunosuppressive Agents/therapeutic use , Sarcoidosis/drug therapy , Tacrolimus/therapeutic use , Female , Humans , Middle Aged
3.
Br J Dermatol ; 147(1): 157-9, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12100201

ABSTRACT

We report the clinical, histopathological and immunological features of follicular erythema and petechiae in a 30-year-old Japanese woman with systemic lupus erythematosus (SLE). Histology showed this eruption to constitute a cutaneous manifestation of SLE. To our knowledge, this is the first reported case of follicular erythema and petechiae in association with SLE. Accordingly, we propose that this rare eruption be termed 'follicular lupus erythematosus'.


Subject(s)
Erythema/etiology , Hair Follicle , Lupus Erythematosus, Systemic/complications , Purpura/etiology , Adult , Erythema/pathology , Female , Hair Follicle/pathology , Humans , Purpura/pathology
4.
Clin Exp Immunol ; 127(2): 283-8, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11876751

ABSTRACT

Matrix metalloproteinases and their specific inhibitors, tissue inhibitors of metalloproteinases (TIMPs), contribute to inflammation-induced tissue destruction and subsequent remodeling for maintenance of tissue homeostasis. Since the production of these enzymes and their inhibitors is regulated by mediators such as proinflammatory cytokines and growth factors, elevated levels of serum TIMPs and/or MMPs have been documented in patients with several inflammatory disorders. In this study, we examined the role of TIMPs and MMPs in the pathogenesis of atopic dermatitis (AD) by evaluating the serum levels of TIMP-1 and MMP-3 in 40 patients with AD and 20 control subjects by ELISA. The serum TIMP-1 levels were significantly higher in AD patients in exacerbation status than in nonatopic subjects, whereas serum MMP-3 levels were not significantly different between them. As a result, AD patients revealed significantly elevated TIMP-1/MMP-3 ratios. The levels of serum TIMP-1 were significantly reduced in AD patients following conventional treatments. Significantly higher values of peripheral eosinophil counts, serum levels of IgE and lactate dehydrogenase, eruption score, and eruption area were noted in the AD patients with elevated TIMP-1 levels when compared with those with normal values. Moreover, the points of chronic eruptions such as lichenification and prurigo were significantly higher in the patients with elevated TIMP-1 levels than those with normal TIMP-1, while those of acute lesions such as oozy/microvesicles and oedema were not different between these groups. Serum TIMP-1 level may be a useful marker to estimate the long-term disease activity of AD.


Subject(s)
Dermatitis, Atopic/blood , Tissue Inhibitor of Metalloproteinase-1/blood , Tissue Inhibitor of Metalloproteinase-3/blood , Adolescent , Adrenal Cortex Hormones/therapeutic use , Adult , Biomarkers , Child , Child, Preschool , Chronic Disease , Dermatitis, Atopic/drug therapy , Enzyme-Linked Immunosorbent Assay , Histamine H1 Antagonists/therapeutic use , Humans , Immunoglobulin E/blood , Psoriasis/blood , Psoriasis/drug therapy , Severity of Illness Index
5.
Am J Pathol ; 157(6): 1875-82, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11106560

ABSTRACT

Transglutaminase 1 (TGase 1) is a Ca(2+)-dependent enzyme which catalyzes epsilon-(gamma-glutamyl)lysine cross-linking of substrate proteins such as involucrin and loricrin to generate the cornified envelope at the cell periphery of the stratum corneum. We have shown that disruption of the TGase 1 gene in mice results in neonatal lethality, absence of the cornified envelope, and impaired skin barrier function. Based on the importance of TGase 1 in epidermal morphogenesis, we have now assessed its role in wound healing. In neonatal mouse skin, TGase 1 mRNA as well as keratin 6alpha was induced in the epidermis at the wound edges as early as 2 hours after injury and that expression continued in the migrating epidermis until completion of re-epithelialization. The TGase 1 enzyme co-localized on the plasma membrane of migrating keratinocytes with involucrin, but not with loricrin, which suggests the premature assembly of the cornified envelope. Similar injuries to TGase 1 knockout mouse skins grafted on athymic nude mice showed substantial delays in wound healing concomitant with sustained K6alpha mRNA induction. From these results, we suggest that activation of the TGase 1gene is essential for facilitated repair of skin injury.


Subject(s)
Gene Expression Regulation , Skin/injuries , Transglutaminases/genetics , Wound Healing/genetics , Wounds, Penetrating/physiopathology , Animals , Keratins/genetics , Mice , Mice, Inbred Strains , Mice, Knockout/genetics , Mice, Nude , Protein Precursors/genetics , RNA, Messenger/metabolism , Skin Transplantation
7.
Clin Exp Immunol ; 121(2): 187-92, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10931130

ABSTRACT

It is suggested that CD30 and CD26 are surface molecules expressed on activated Th2 and Th1 cells, respectively. We examined plasma levels of soluble CD26 (sCD26) and sCD30 in patients with atopic dermatitis (AD) when their eruptions were aggravated and in non-atopic healthy controls, and then analysed the possible correlation between these values and the levels of several clinical markers. The plasma levels of both sCD30 and sCD26 were significantly higher in AD patients than in controls, both in exacerbation status and after conventional treatment. Multiple regression analyses showed that plasma sCD30 was a much better predictor of the levels of serum IgE, serum LDH and plasma sCD25, and the area and the score of AD eruption than sCD26, although elevated levels of both sCD30 and sCD26 are associated with these clinical predictors of AD. Importantly, sCD30 plasma levels decreased significantly in AD patients after conventional treatment, while no significant transition was noted in the concentration of sCD26. Moreover, a significant reduction of sCD30 levels was observed in the group of patients whose eruption score was reduced > 50%, whereas it was not in those < 50%. These findings provide evidence that the successful treatment of AD is associated with down-activation of Th2.


Subject(s)
Dermatitis, Atopic/blood , Dipeptidyl Peptidase 4/blood , Ki-1 Antigen/blood , Th1 Cells/immunology , Th2 Cells/immunology , Adolescent , Adult , Biomarkers , Child , Dermatitis, Atopic/immunology , Eosinophilia/etiology , Female , Humans , Immunoglobulin E/blood , Interleukins/metabolism , L-Lactate Dehydrogenase/blood , Male , Receptors, Interleukin-2/blood , Severity of Illness Index , Solubility , Th1 Cells/metabolism , Th2 Cells/metabolism
9.
Br J Dermatol ; 142(3): 509-12, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10735960

ABSTRACT

A 72-year-old woman had suffered from parapsoriasis en plaque (large plaque type) controlled by topically applied psoralen ultraviolet A (PUVA) therapy. The parapsoriasis lesions gradually disappeared, but numerous tiny red papules with pruritus appeared over the forearms and lower legs 120 days after starting PUVA therapy. These papules developed to form violaceous plaques. Histological findings demonstrated the characteristics of lichen planus. Two months later, tense bullae developed on the plaques and on uninvolved skin of the limbs. These were subepidermal, with linear deposits of IgG and C3 along the basement membrane zone (BMZ) in immunofluorescence of peribullous skin, and immunodeposits of type IV collagen along the floor of the bullae. We therefore, diagnosed lichen planus pemphigoides (LPP). Using systemic and topical steroid therapy, the lesions rapidly resolved and there has been no recurrence. This case suggests that the combination of basal cell injuries caused by chronic inflammation and PUVA therapy could expose BMZ components to autoreactive lymphocytes and induce LPP.


Subject(s)
Lichen Planus/etiology , PUVA Therapy/adverse effects , Pemphigoid, Bullous/etiology , Aged , Basement Membrane/pathology , Collagen/analysis , Complement C3/analysis , Female , Humans , Immunoglobulin G/analysis , Lichen Planus/pathology , Parapsoriasis/drug therapy , Pemphigoid, Bullous/pathology
10.
Br J Dermatol ; 142(3): 543-7, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10735969

ABSTRACT

We report the clinical and histopathological features of a keratosis that developed in association with syringocystadenoma papilliferum. This tumour shows a pinkish, pedunculated, spherical nodule with a cerebriform surface and visible keratinous plugs. In addition to the typical features of syringocystadenoma papilliferum, the tumour shows many hyperkeratotic columns surrounded by acanthotic epidermis with the characteristics of trichilemmal keratinization and keratohyalin granules. This keratosis seems to be derived from the middle to lower portion of the apocrine acrosyringium, based on the distribution of keratohyalin granules and the direct connection with the apocrine acrosyringium in an early lesion. Accordingly, we propose to identify this rare keratosis as apocrine acrosyringeal keratosis.


Subject(s)
Acrospiroma/pathology , Adenoma, Sweat Gland/pathology , Keratosis/pathology , Neoplasms, Multiple Primary/pathology , Sweat Gland Neoplasms/pathology , Adult , Diagnosis, Differential , Humans , Male
11.
Contact Dermatitis ; 42(2): 90-4, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10703631

ABSTRACT

10 cases of contact dermatitis which began during the application of povidone-iodine preparations were examined with patch tests using 2 kinds of povidone-iodine preparations and their ingredients, i.e., povidone-iodine, polyoxyethylene nonylphenyl ether and glycerin, and also the components of povidone-iodine, i.e., iodine and polyvinylpyrrolidone. All 10 cases reacted positively to the povidone-iodine preparations and povidone-iodine, 3 out of the 10 to polyoxyethylene nonylphenyl ether, 1 out of the 9 tested to iodine, while no positive response was found to glycerin or polyvinyl-pyrrolidone. It was difficult to distinguish between allergic responses from irritation, as responses to patches of povidone-iodine and its preparations usually include irritation at high frequencies. Based on comparison of results with a control group, however, those showing + or stronger reactions to 2% povidone-iodine at days 3 to 5 were considered to be allergic. Thus, 4 out of the 10 cases were considered as sensitization to povidone-iodine. Another 3 cases were found to be polyoxyethylene nonylphenyl ether sensitized, and another 1 iodine sensitized, while the patch test reactions of the other 2 were considered to have been elicited by irritation.


Subject(s)
Anti-Infective Agents, Local/adverse effects , Dermatitis, Allergic Contact/classification , Dermatitis, Irritant/classification , Iodophors/adverse effects , Patch Tests , Povidone-Iodine/adverse effects , Adult , Aged , Aged, 80 and over , Allergens/adverse effects , Female , Glycerol/adverse effects , Humans , Iodine/adverse effects , Irritants/adverse effects , Male , Middle Aged , Pharmaceutic Aids/adverse effects , Polyethylene Glycols/adverse effects , Povidone/adverse effects , Surface-Active Agents/adverse effects
12.
J Cutan Pathol ; 27(2): 87-92, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10678704

ABSTRACT

The case of a Japanese woman with glomeruloid hemangioma, an initial marker for POEMS syndrome, is reported. Her cutaneous lesions were multiple and consisted of glomeruloid hemangiomas, cherry-type capillary hemangiomas, and a mixture of both. The specimens of glomeruloid hemangiomas were studied by paraffin section immunohistochemistry with a large panel of antibodies and electron microscopy, respectively. The lesions, whose size ranged from minute foci to large nodules, were composed of anastomosing vascular channels resembling renal glomeruli and had irregular lumina, often featuring capillaries and sinusoid-like spaces. The vascular channels were lined by a single layer of endothelial cells, which showed two types of cells. The capillary-type endothelium possessed large vesicular nuclei with open chromatin and large amount of cytoplasm. The sinusoidal endothelium possessed small basal nuclei with dense chromatin as well as scant amount of cytoplasm. The former cells had a characteristic CD31+/CD34+/UEA I+/CD68- phenotype. Some of these cells ultrastructurally showed intracytoplasmic lumen formation. The latter cells had a characteristic CD31+/CD34-/UEA I-/CD68+ phenotype. The present study shows that glomeruloid hemangioma has unique morphologic and immunologic features that differ from the traditional hemangiomas as well as littoral cell angioma of the spleen.


Subject(s)
Hemangioma/complications , Hemangioma/pathology , POEMS Syndrome/complications , POEMS Syndrome/pathology , Skin Neoplasms/complications , Skin Neoplasms/pathology , Antigens, CD/analysis , Antigens, CD/immunology , Antigens, CD34/analysis , Antigens, CD34/immunology , Antigens, Differentiation, Myelomonocytic/analysis , Antigens, Differentiation, Myelomonocytic/immunology , Endothelium/chemistry , Endothelium/pathology , Endothelium/ultrastructure , Female , Hemangioma/immunology , Humans , Immunophenotyping , Macrophages/ultrastructure , Microscopy, Electron , Middle Aged , POEMS Syndrome/immunology , Platelet Endothelial Cell Adhesion Molecule-1/analysis , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Skin Neoplasms/immunology
13.
J Invest Dermatol ; 114(2): 247-52, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10651982

ABSTRACT

Extracellular lipids of the stratum corneum, which are composed of cholesterol, fatty acid, and ceramides, are essential for the epidermal permeability barrier function. With damage to the barrier, a decreased capacity for epidermal lipid biosynthesis in aged epidermis results in an impaired repair response. Mevalonic acid is an intermediate after the rate-limiting step in cholesterol biosynthesis, which is catalyzed by 3-hydroxy-3-methylglutaryl coenzyme A reductase. In the present study, we investigated the effect of topical mevalonic acid on the murine epidermal permeability barrier function, comparing it with that of cholesterol. Topical treatment with acetone caused linear increases in transepidermal water loss, in proportion to the number of treatments more rapidly in aged mice than in young mice. Administration of mevalonic acid on aged murine epidermis enhanced its resistance against damage and the recovery rate of barrier function from acute barrier disruption. In contrast, although cholesterol also had the same effect, it required a much higher amount than mevalonic acid. In young mice, neither mevalonic acid nor cholesterol had any effect on resistance against acetone damage nor the recovery rate from acetone damage. In the skin of mice topically administered with mevalonic acid, stimulation of cholesterol synthesis and 3-hydroxy-3-methylglutaryl coenzyme A reductase activity were both observed, whereas none was seen with stimulation by equimolar cholesterol. These data indicate that a topical application of mevalonic acid enhances barrier recovery in aged mice, which is accompanied by not only acceleration of cholesterol synthesis from mevalonic acid but also stimulation of the whole cholesterol biosynthesis.


Subject(s)
Aging/physiology , Cell Membrane Permeability/physiology , Cholesterol/biosynthesis , Mevalonic Acid/pharmacology , Skin/cytology , Administration, Topical , Animals , Fatty Acids, Nonesterified/analysis , Homeostasis , Hydroxymethylglutaryl CoA Reductases/metabolism , Mice , Mice, Hairless , Skin/chemistry
14.
Brain Res ; 887(1): 53-62, 2000 Dec 22.
Article in English | MEDLINE | ID: mdl-11134589

ABSTRACT

The olfactory neuroepithelium of the mammalian nervous system manifests continuous neurogenesis throughout life. Recent studies suggest that neurotrophic factors and their receptors may play a role in the regulation of development and regeneration in the olfactory system. However, there have been very few in vivo studies investigating the effect of exogenous neurotrophic factors in the olfactory system. In the present study, nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) were administered into the rat olfactory mucosa for 5 days just after the transection of the olfactory nerve. We then examined the effect of exogenous neurotrophic factors on the degenerative changes in axotomized olfactory receptor neurons (ORNs). Further, we examined the location of their receptors, Trk A and Trk B. We found that both mature and immature ORNs expressed more intense signals for olfactory marker protein and beta-tubulin mRNAs, respectively, when NGF was applied to the axotomized olfactory neuroepithelium for 5 days, compared to the ORNs of saline-treated controls. BDNF at a 10 microg total dose did not show this effect. The effect of NGF applied onto the olfactory epithelium is consistent with the immunohistochemical finding that Trk A was present in the dendrites and axon bundles in normal and axotomized ORNs. These results suggest that NGF may protect the degenerative changes in mature and immature ORNs following axotomy through the binding to the Trk A receptor located on the surface of the olfactory epithelium.


Subject(s)
Brain-Derived Neurotrophic Factor/pharmacology , Nerve Degeneration/metabolism , Nerve Growth Factor/pharmacology , Nerve Tissue Proteins/drug effects , Olfactory Mucosa/drug effects , Olfactory Receptor Neurons/drug effects , Animals , Axotomy , Brain-Derived Neurotrophic Factor/therapeutic use , Male , Nerve Degeneration/drug therapy , Nerve Growth Factor/therapeutic use , Nerve Tissue Proteins/metabolism , Olfactory Marker Protein , Olfactory Mucosa/metabolism , Olfactory Receptor Neurons/metabolism , RNA, Messenger/drug effects , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptor, trkA/metabolism , Receptor, trkB/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...